Clinical trials recruiting for CRC (Colorectal Cancer)
15
Recruiting trials
22
US states with sites
10
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cetuximab | 3 |
| Pembrolizumab | 3 |
| mFOLFIRINOX | 2 |
| mFOLFOX6 | 2 |
| ADU-1805 | 1 |
| ALTA3263 | 1 |
| BBO-10203 | 1 |
| BBO-11818 | 1 |
| Chemotherapy Regimen 1 | 1 |
| Chemotherapy Regimen 2 | 1 |
| Chemotherapy Regimen 3 | 1 |
| GFH375 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 4 |
| Texas | 4 |
| Virginia | 4 |
| Massachusetts | 3 |
| New York | 3 |
| Ohio | 3 |
| California | 2 |
| Michigan | 2 |
| Missouri | 2 |
| Oklahoma | 2 |
| Tennessee | 2 |
| Arizona | 1 |
Top cities
Boston, Massachusetts 3Fairfax, Virginia 3New York, New York 3San Antonio, Texas 3Dallas, Texas 2Houston, Texas 2Los Angeles, California 2Nashville, Tennessee 2Oklahoma City, Oklahoma 2St Louis, Missouri 2
Self-screener
Recruiting trials
- A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
- A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size
- A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
- A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12D Mutation
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
- An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
- Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer
- Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
- PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
- Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
Related conditions
Trials recruiting for CRC (Colorectal Cancer) often also study these conditions. Each links to its own recruiting-trial list.
Colorectal cancer 1359Lung cancer 2180Solid Tumor, Adult 38PDAC - Pancreatic Ductal Adenocarcinoma 21Pancreatic cancer 870Non-small cell lung cancer 507Adenoma Colon 4Solid Tumor Malignancies 6Refractory Cancer 6PDAC 11
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for CRC (Colorectal Cancer) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.